Medaz Super Speciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 21-12-2024
- Paid Up Capital ₹ 7.50 M
as on 21-12-2024
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.75 Cr
as on 21-12-2024
- Satisfied Charges ₹ 2.33 M
as on 21-12-2024
- Revenue 75.11%
(FY 2022)
- Profit 2926.00%
(FY 2022)
- Ebitda 61.39%
(FY 2022)
- Net Worth 302.04%
(FY 2022)
- Total Assets -2.71%
(FY 2022)
About Medaz Super Speciality Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹1.75 Cr. The company has closed loans amounting to ₹2.33 M, as per Ministry of Corporate Affairs (MCA) records.
Zeyaur Azad and Farheen Aslam serve as directors at the Company.
- CIN/LLPIN
U74999BR2016PTC032969
- Company No.
032969
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medaz Super Speciality Hospital?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Zeyaur Azad  | Managing Director | 01-Dec-2016 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Farheen Aslam | Director | 01-Dec-2016 | Current |
Financial Performance of Medaz Super Speciality Hospital.
Medaz Super Speciality Hospital Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 75.11% increase. The company also saw a substantial improvement in profitability, with a 2926% increase in profit. The company's net worth Soared by an impressive increase of 302.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medaz Super Speciality Hospital?
In 2020, Medaz Super Speciality Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 31 Oct 2020 | ₹1.85 M | Open |
Canara Bank Creation Date: 20 Oct 2018 | ₹1.57 Cr | Open |
Canara Bank Creation Date: 24 Jun 2020 | ₹2.33 M | Satisfied |
How Many Employees Work at Medaz Super Speciality Hospital?
Medaz Super Speciality Hospital has a workforce of 92 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medaz Super Speciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medaz Super Speciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
